In individuals with certain malignant tumours such as PTC, pancreatic neuroendocrine neoplasm, small cell lung cancer and Merkel cell carcinoma, loss of CD56 expression has been linked to malignant transformation, tumour growth and a dismal prognosis [24–27]. The gene discussed is NCAM1; the disease is Merkel cell skin cancer.